These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
778 related articles for article (PubMed ID: 23685952)
1. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Chen K; Huang YH; Chen JL Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952 [TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors. Hong IS; Lee HY; Nam JS Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037 [TBL] [Abstract][Full Text] [Related]
3. Stem cell programs in cancer initiation, progression, and therapy resistance. Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274 [TBL] [Abstract][Full Text] [Related]
4. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Marquardt S; Solanki M; Spitschak A; Vera J; PĆ¼tzer BM Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic approaches targeting cancer stem cells. Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025 [TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways. Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243 [TBL] [Abstract][Full Text] [Related]
8. Can nanomedicines kill cancer stem cells? Zhao Y; Alakhova DY; Kabanov AV Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657 [TBL] [Abstract][Full Text] [Related]
9. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy. Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363 [TBL] [Abstract][Full Text] [Related]
10. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells. Zhang Z; Deng Q; Xiao C; Li Z; Yang X Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133 [TBL] [Abstract][Full Text] [Related]
11. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target. Yan Y; Zuo X; Wei D Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504 [TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells: perspectives for therapeutic targeting. Maccalli C; De Maria R Cancer Immunol Immunother; 2015 Jan; 64(1):91-7. PubMed ID: 25104304 [TBL] [Abstract][Full Text] [Related]
13. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells. Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127 [TBL] [Abstract][Full Text] [Related]
14. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells. Kim JK; Jeon HY; Kim H Arch Pharm Res; 2015 Mar; 38(3):389-401. PubMed ID: 25502807 [TBL] [Abstract][Full Text] [Related]
15. Novel therapeutic strategies for targeting liver cancer stem cells. Oishi N; Wang XW Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity and targeting of pancreatic cancer stem cells. Penchev VR; Rasheed ZA; Maitra A; Matsui W Clin Cancer Res; 2012 Aug; 18(16):4277-84. PubMed ID: 22896694 [TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting. Eun K; Ham SW; Kim H BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397 [TBL] [Abstract][Full Text] [Related]
18. Implications of cancer stem cells in the treatment of cancer. Pan CX; Zhu W; Cheng L Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899 [TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells, metabolism, and therapeutic significance. Yang M; Liu P; Huang P Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589 [TBL] [Abstract][Full Text] [Related]
20. Approaches for targeting cancer stem cells drug resistance. Rosa R; D'Amato V; De Placido S; Bianco R Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]